Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BibbInstruments ABFRA:V0R -0.61%21 EV-to-OCF is -2.02 as of Sep. 13, 2026. GuruFocus rates FRA:V0R with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 851 Medical Devices & Instruments companies, BibbInstruments AB ranks better than 67.92% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, BibbInstruments AB's Enterprise Value is €2.92 Mil.
BibbInstruments AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was €-1.45 Mil. Therefore, BibbInstruments AB's EV-to-OCF for today is -2.02.
The historical rank and industry rank for BibbInstruments AB's EV-to-OCF or its related term are showing as below:
FRA:V0R'
s EV-to-OCF Range Over the Past 10 Years
Min: -30.51 Med: -7.4 Max: -0.86
Current: -2.08
During the past 11 years, the highest EV-to-OCF of BibbInstruments AB was -0.86. The lowest was -30.51. And the median was -7.40.
FRA:V0R's EV-to-OCF is ranked better than 67.92% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 7.79
vs FRA:V0R: -2.08
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
BibbInstruments AB (FRA:V0R) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
BibbInstruments AB's PE Ratio (TTM) for today is calculated as:
BibbInstruments AB's share price for today is €0.0328.
BibbInstruments AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.028.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
BibbInstruments AB EV-to-OCF Related Terms
BibbInstruments AB EV-to-OCF Historical Data
* Premium members only.
The historical data trend for BibbInstruments AB's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, BibbInstruments AB's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BibbInstruments AB EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BibbInstruments AB's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where BibbInstruments AB's EV-to-OCF falls into.
BibbInstruments AB's current Enterprise Value is €2.92 Mil.
BibbInstruments AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.45 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BibbInstruments AB (FRA:V0R) has a EV-to-OCF of -2.02 as of Sep. 13, 2026. According to the industry distribution chart, BibbInstruments AB ranks #273 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 32.1%.
Is BibbInstruments AB's EV-to-OCF too high?
BibbInstruments AB's current EV-to-OCF is -2.02. Based on the distribution chart, BibbInstruments AB ranks #273 out of 851 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, BibbInstruments AB has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does BibbInstruments AB's EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, BibbInstruments AB ranks #273 out of 851 companies for EV-to-OCF. This puts BibbInstruments AB in the upper half of its industry. The industry median EV-to-OCF is 7.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.79, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BibbInstruments AB's current EV-to-OCF is -2.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BibbInstruments AB stock overvalued right now?
BibbInstruments AB (FRA:V0R) has a current EV-to-OCF of -2.02. The current EV-to-OCF is -2.02. BibbInstruments AB's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For BibbInstruments AB (FRA:V0R), the current EV-to-OCF is -2.02 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BibbInstruments AB develops disposable biopsy instrumentation under the brand EndoDrill for early detection of cancer tumors, especially in deep-tissue tumors. The product portfolio includes six disposable instruments based on the patented EndoDrill technology and a novel biopsy method still under development. The instruments will be used for tissue sampling (biopsy) of the most common types of cancer, for example; lung, breast, colorectal, prostate and stomach cancer.
21GF Score
Get the complete analysis for FRA:V0R
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:V0R has been successfully added to your 
